1. EMA (2012) Guideline on good pharmacovigilance practices (GVP). EMA/873138/2011
2. European Commission (2004) Detailed guidance on the European database of suspected unexpected serious adverse reactions
3. European Commission (2006) ENTR/CT 3, Detailed guidance on the collection, verification, and presentation of adverse reaction reports arising from clinical trials on medicinal products for human use
4. European Commission (2009) Guideline on summary of product characteristics, Revision 2 (SmPC)
5. ICH (1994) Guideline clinical safety datamanagement E2A